Pfizer wins $10B obesity drug takeover battle
Pfizer triumphs in dramatic $10 billion bidding war for obesity drug maker Metsera, securing crucial White House-backed deal to compete in weight-loss market. Read the full story.
Category : Search result: pharmaceutical barrier materials
Waterloo's Inclusive Playground Gets Major Upgrade
Waterloo Park's popular inclusive play area expands with exciting new equipment designed for children of all abilities, creating a more accessible recreational space for families across the region.
Trump's Plan to Slash Obesity Drug Prices
Former President Donald Trump unveils ambitious strategy to dramatically reduce costs of groundbreaking weight-loss medications, promising relief for millions struggling with obesity.
Trump's Drug Price Plan Backfires, Helps Democrats
Former President Trump's proposal to regulate Medicare drug prices faces unexpected consequences as Democrats leverage it to attack Republican positions on healthcare, creating political turmoil.
Trump Reveals Deal to Lower Obesity Drug Costs
Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giant to make obesity drugs more affordable and accessible across the United States.
New Brunswick unveils 5-year accessibility plan
New Brunswick launches comprehensive strategy to create barrier-free province by addressing physical, digital, and social accessibility challenges through multi-year action plan.
Trump Obesity Drug Deal Boosts Pharma Stocks
Major pharmaceutical giants Novo Nordisk and Eli Lilly experience significant stock surges as former President Donald Trump considers a groundbreaking obesity drug partnership, potentially revolutionizing weight loss treatment accessibility.
NEXE's $1.2M Pod Deal Fuels Bridgehead's Costco Launch
Canadian sustainability leader NEXE Innovations secures major compostable coffee pod order as Bridgehead Coffee prepares for nationwide Costco launch across Canada.
BC Libraries Struggle with Soaring eBook Demand
British Columbia libraries are facing a digital crisis as exploding demand for eBooks and digital materials outpaces available funding, creating growing wait times and access barriers for patrons across the province.
Top 15 Korean Beauty Finds for Fall 2025
Discover the top 15 Korean beauty innovations transforming skincare routines this autumn. From hydrating serums to protective barriers, these K-beauty finds will revolutionize your fall regimen.
Pharma Veteran Dr. Andreas Wallnofer Joins Optigo Board
Optigo Biotherapeutics strengthens leadership with renowned pharmaceutical expert Dr. Andreas Wallnofer joining its Board of Directors as the company progresses toward Investigational New Drug (IND) enabling studies.
Former Refugee Elected Montreal Mayor in Historic Victory
In a groundbreaking political victory, Balarama Holness becomes Montreal's first mayor who arrived in Canada as a refugee, shattering barriers and inspiring new generations of Canadians.
Top FDA Drug Official Resigns Amid Federal Probe
The FDA's principal deputy commissioner, Dr. Namandjé Bumpus, resigns following federal probe into undisclosed concerns about her conduct, marking significant leadership shakeup.
Ardena Appoints Chief Quality and Information Officers
Ardena strengthens its leadership with strategic hires of Chief Quality Officer and Chief Information Officer to drive operational excellence and digital transformation in pharmaceutical services.
Kimberly-Clark Buys Tylenol Maker in $48.7B Deal
In a landmark move reshaping the consumer healthcare landscape, Kimberly-Clark announces its acquisition of Kenvue, the company behind Tylenol and other household brands, in a staggering US$48.7 billion transaction that creates a new industry powerhouse.
Kimberly-Clark Buys Tylenol Maker Kenvue for $4.87B
In a landmark healthcare deal, Kimberly-Clark acquires Kenvue, the consumer health giant behind Tylenol, Band-Aid and Listerine, reshaping the North American healthcare landscape.
Fuel Train Derailment Near Kamloops Sparks Emergency
A CPKC freight train carrying hazardous fuels derailed near Kamloops, BC, triggering an emergency response and evacuation alert for nearby properties as authorities assess the environmental risk.
Blood Pressure Medication Recall Over Cancer Risk
Health Canada issues urgent recall for specific blood pressure medications containing potentially carcinogenic nitrosamine impurity. Learn which lots are affected and what steps to take.
Eli Lilly's Weight Loss Drugs Spark Billion-Dollar Bidding War
Pharmaceutical giant Eli Lilly reports explosive growth driven by Mounjaro and Zepbound, creating intense investor competition and reshaping the obesity treatment landscape.
Weight-Loss Pill Race Revolutionizes Healthcare Market
Pharmaceutical giants and startups race to develop next-generation weight-loss treatments as demand soars and market valuations skyrocket in this healthcare revolution.
Boehringer Ingelheim Licenses Novel Autoimmune Treatment
Global pharmaceutical leader Boehringer Ingelheim secures exclusive license from Kyowa Kirin to develop innovative autoimmune disease treatment, targeting conditions like lupus and rheumatoid arthritis with novel therapeutic approach.
Ex-Pharmacy Manager Guilty, Fined $5K for Multiple Violations
A former Melita pharmacy manager faces consequences after being convicted of multiple professional misconduct charges, including improper prescription practices and record-keeping failures.
Page 3 of 3